在养老院的老年人中认知功能和痴呆风险因素:印尼梅丹的一项观察性队列研究
Siska Evi Martina1, Fasihah Irfani Fitri2, Alexander Fernando Kawas Sibero3
1Department of Gerontology Nursing, Faculty of Pharmacy and Health Sciences, Sari Mutiara Indonesia University, Medan, Indonesia.
Belitung nursing journal
|November 28, 2025
概括
这项研究发现,印尼养老院居民的认知功能在六个月内下降,特别是在政府设施. 较高的体力活动水平与老年人更好的认知健康有关.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 印尼面临着人口老龄化和在资源有限的养老院中痴呆症患病率的挑战.
- 有限的数据存在于认知衰退和痴呆的风险因素在这个人口.
- 早期识别痴呆症对于有效的干预和管理至关重要.
研究的目的:
- 调查认知功能变化,并确定印尼养老院居民的痴呆风险因素.
- 为了比较政府和私人养老院之间的认知轨迹.
主要方法:
- 一项为期6个月的观察性队列研究,涉及政府和私人养老院的162名参与者.
- 使用蒙特利尔认知评估 (MoCA INA) 进行认知查和体育活动问卷 (SPAQ-I).
- 采用描述性统计学,麦克纳马,奇平方,费舍尔的精确,独立的t测试和多变量回归来进行数据分析.
主要成果:
- 政府养老院居民的认知功能在六个月内显著下降,与私人机构不同.
- 私人养老院的住户报告说,他们的身体活动水平更高.
- 高龄和较低的体力活动与较低的认知得分有显著的关联.
结论:
- 痴呆症查有助于早期识别和管理认知障碍,使更好的护理规划成为可能.
- 较高的体力活动是与老年人更好的认知功能相关的可修改因素.
- 促进身体活动的干预措施可能有助于在养老院环境中保持认知健康.
相关概念视频
Dementia
487
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
487
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitive Development During Adulthood
749
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
749
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
517
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
517


